Literature DB >> 29498184

Sphingosine-1-phosphate receptors and innate immunity.

Arielle M Bryan1, Maurizio Del Poeta1,2,3.   

Abstract

Sphingosine-1-phosphate (S1P) is a signalling lipid that regulates many cellular processes in mammals. One well-studied role of S1P signalling is to modulate T-cell trafficking, which has a major impact on adaptive immunity. Compounds that target S1P signalling pathways are of interest for immune system modulation. Recent studies suggest that S1P signalling regulates many more cell types and processes than previously appreciated. This review will summarise current understanding of S1P signalling, focusing on recent novel findings in the roles of S1P receptors in innate immunity.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  G protein coupled receptors; Inhibitors; Innate immunity; S1P receptors; Sphingolipid; Sphingosine-1-phosphate

Mesh：

Substances：

Year:  2018        PMID： 29498184      PMCID： PMC5893408          DOI： 10.1111/cmi.12836

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN： 1462-5814            Impact factor:   3.715


  87 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

Review 2.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

Authors:  Jason G Cyster; Susan R Schwab
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

3.  Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.

Authors:  Lutz Achtnichts; Otilia Obreja; Anna Conen; Christoph A Fux; Krassen Nedeltchev
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

Review 4.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

5.  Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor.

Authors:  Thierry Walzer; Laura Chiossone; Julie Chaix; Andrew Calver; Claude Carozzo; Laure Garrigue-Antar; Yannick Jacques; Myriam Baratin; Elena Tomasello; Eric Vivier
Journal:  Nat Immunol       Date:  2007-10-28       Impact factor: 25.606

6.  EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue.

Authors:  M H Gräler; G Bernhardt; M Lipp
Journal:  Genomics       Date:  1998-10-15       Impact factor: 5.736

Review 7.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

Review 8.  Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.

Authors:  Montserrat Serra; Julie D Saba
Journal:  Adv Enzyme Regul       Date:  2009-11-13

9.  S1PR5 is pivotal for the homeostasis of patrolling monocytes.

Authors:  Emilie Debien; Katia Mayol; Vincent Biajoux; Cécile Daussy; Mercedes Gomez De Aguero; Morgan Taillardet; Nicolas Dagany; Lilia Brinza; Thomas Henry; Bertrand Dubois; Dominique Kaiserlian; Jacqueline Marvel; Karl Balabanian; Thierry Walzer
Journal:  Eur J Immunol       Date:  2013-04-30       Impact factor: 5.532

10.  Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury.

Authors:  Amandeep Bajwa; Liping Huang; Hong Ye; Krishna Dondeti; Steven Song; Diane L Rosin; Kevin R Lynch; Peter I Lobo; Li Li; Mark D Okusa
Journal:  J Immunol       Date:  2012-08-01       Impact factor: 5.422
View more
  34 in total

1.  Involvement of Receptor-Mediated S1P Signaling in EGF-Induced Macropinocytosis in COS7 Cells.

Authors:  Shubi Ambwene Matovelo; Lifang Zhang; Nesma Nabil Ibrahim Mohamed; Taketoshi Kajimoto; Takeshi Ijuin; Taro Okada; Shun-Ichi Nakamura
Journal:  Kobe J Med Sci       Date:  2020-11-17

2.  Pseudomonas aeruginosa stimulates nuclear sphingosine-1-phosphate generation and epigenetic regulation of lung inflammatory injury.

Authors:  Viswanathan Natarajan; Panfeng Fu; David L Ebenezer; Evgeny V Berdyshev; Irina A Bronova; Yuru Liu; Chinnaswamy Tiruppathi; Yulia Komarova; Elizaveta V Benevolenskaya; Vidyani Suryadevara; Alison W Ha; Anantha Harijith; Rubin M Tuder
Journal:  Thorax       Date:  2019-02-05       Impact factor: 9.139

Review 3.  Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.

Authors:  Jie Wang; Idan Goren; Bo Yang; Sinan Lin; Jiannan Li; Michael Elias; Claudio Fiocchi; Florian Rieder
Journal:  Aliment Pharmacol Ther       Date:  2021-12-21       Impact factor: 8.171

4.  Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts.

Authors:  SiddabasaveGowda B Gowda; Divyavani Gowda; Vasundhara Kain; Hitoshi Chiba; Shu-Ping Hui; Charles E Chalfant; Vibhu Parcha; Pankaj Arora; Ganesh V Halade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-20       Impact factor: 4.733

Review 5.  Lipid Ligands and Allergenic LTPs: Redefining the Paradigm of the Protein-Centered Vision in Allergy.

Authors:  Zulema Gonzalez-Klein; Diego Pazos-Castro; Guadalupe Hernandez-Ramirez; Maria Garrido-Arandia; Araceli Diaz-Perales; Jaime Tome-Amat
Journal:  Front Allergy       Date:  2022-05-19

Review 6.  Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease.

Authors:  Bram Verstockt; Stefania Vetrano; Azucena Salas; Shadi Nayeri; Marjolijn Duijvestein; Niels Vande Casteele
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 73.082

Review 7.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.

Authors:  Youn-Jeong Choi; Julie D Saba
Journal:  Adv Biol Regul       Date:  2018-09-25

8.  NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα(12/13)/MAPK signaling pathway.

Authors:  Lei Hou; Zhi Zhang; Le Yang; Na Chang; Xinhao Zhao; Xuan Zhou; Lin Yang; Liying Li
Journal:  J Mol Med (Berl)       Date:  2021-01-02       Impact factor: 4.599

9.  FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.

Authors:  Arielle M Bryan; Jeehyun Karen You; Travis McQuiston; Cristina Lazzarini; Zhijuan Qiu; Brian Sheridan; Barbara Nuesslein-Hildesheim; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

10.  Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Maria-Eleptheria Evangelopoulos; Theodore Argyrakos; John S Tzartos; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Georgios Velonakis; Panagiotis Toulas; Elias Gialafos; Antonios Dimitrakopoulos; Erasmia Psimenou; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Ther Adv Neurol Disord       Date:  2021-05-18       Impact factor: 6.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.